studi
report
human
bocaviru
hbov
children
respiratori
tract
infect
rti
occasion
adult
search
hbov
dna
nasopharyng
aspir
npa
adult
exacerb
chronic
bronchiti
pneumonia
children
hospit
acut
rti
asymptomat
children
winter
canada
hbov
detect
npa
symptomat
adult
symptomat
children
asymptomat
children
undergo
elect
surgeri
anoth
viru
detect
hbovposit
npa
symptomat
children
two
clade
hbov
identifi
ed
pathogen
role
hbov
rti
uncertain
frequent
detect
symptomat
asymptomat
children
commonli
found
virus
symptomat
children
h
uman
bocaviru
hbov
newli
describ
human
viru
close
relat
bovin
parvoviru
canin
minut
viru
current
classifi
ed
genu
bocaviru
within
famili
parvovirida
viru
fi
rst
identifi
ed
respiratori
tract
specimen
swedish
children
lower
respiratori
tract
infect
rti
nucleic
acid
amplifi
cation
detect
hbov
respiratori
sampl
children
acut
respiratori
diseas
incid
rate
rang
howev
pathogen
role
hbov
uncertain
virus
frequent
detect
hbovposit
children
lower
rti
rang
object
studi
describ
incid
clinic
manifest
hbov
infect
children
adult
respiratori
tract
symptom
includ
control
group
children
without
symptom
respiratori
sampl
adult
obtain
previou
studi
conduct
decemb
april
universityaffi
liat
hospit
provinc
quebec
canada
two
group
patient
enrol
year
age
chronic
obstruct
pulmonari
diseas
copd
came
emerg
depart
exacerb
ill
includ
patient
pneumonia
year
age
without
copd
admit
hospit
diagnosi
communityacquir
pneumonia
patient
exclud
studi
came
hospit
day
onset
symptom
respiratori
sampl
children
obtain
casecontrol
studi
result
publish
particip
includ
children
year
age
hospit
decemb
april
laval
univers
hospit
center
quebec
citi
quebec
canada
casepati
children
admit
acut
rti
mostli
bronchiol
pneumon
laryngotracheobronch
nasopharyng
aspir
npa
collect
part
investig
ill
specifi
c
questionnair
complet
admiss
research
nurs
presenc
parent
end
hospit
chart
children
review
collect
clinic
laboratori
data
elig
control
children
hospit
period
elect
surgeri
ear
nose
throat
surgeri
case
children
concomit
respiratori
symptom
fever
admiss
studi
nurs
obtain
sign
consent
parent
npa
obtain
surgeri
origin
studi
review
approv
ethic
committe
particip
healthcar
center
pediatr
casepati
control
adult
casepati
npa
specimen
previous
analyz
use
multiplex
realtim
pcr
assay
infl
uenza
b
virus
human
respiratori
syncyti
viru
hrsv
human
metapneumoviru
hmpv
symptomat
children
viral
cultur
antigen
detect
assay
perform
upon
request
treat
physician
remain
specimen
frozen
subsequ
hbov
pcr
studi
nucleic
acid
extract
npa
use
qiaamp
viral
rna
mini
kit
qiagen
inc
mississauga
ontario
canada
duplex
hbov
pcr
taqman
assay
use
amplifi
conserv
region
gene
describ
except
forward
primer
replac
primer
ttg
ttt
ggt
ggg
arg
probe
label
uorescein
fam
uorescein
tet
end
quencher
end
amplicon
bp
bp
respect
duplex
amplifi
cation
conduct
use
forward
primer
revers
primer
primer
taqman
probe
use
concentr
mmoll
gene
mmoll
gene
amplifi
cation
master
mixtur
consist
mmoll
mgcl
mgml
bovin
serum
albumin
mmoll
deoxynucleotid
triphosph
amersham
bioscienc
uppsala
sweden
mmoll
trishcl
mmoll
kcl
u
promega
taq
dna
polymeras
fisher
scientifi
c
markham
ontario
canada
combin
taqstart
antibodi
bd
bioscienc
clontech
palo
alto
ca
usa
dna
fi
nal
volum
pcr
amplifi
cation
cycl
perform
smart
cycler
thermal
cycler
cepheid
sunnyval
ca
usa
pcr
extens
step
min
perform
end
cycl
protocol
hbov
infect
defi
ned
posit
pcr
result
duplex
assay
sensit
genom
copi
gene
target
basi
quantifi
cation
analysi
posit
control
plasmid
half
hbovposit
sampl
randomli
select
phylogenet
analysi
consist
amplifi
sequenc
region
gene
describ
nucleotid
sequenc
studi
well
prototyp
sequenc
type
st
enter
multipl
align
gener
clustalw
softwar
version
wwwmolecularevolutionorgsoftwareclustalw
correct
fi
nal
visual
inspect
seqlab
applic
wisconsin
packag
version
accelri
san
diego
ca
usa
phylogenet
analys
conduct
mega
version
softwar
use
distanc
method
neighborjoin
algorithm
paramet
topolog
accuraci
tree
evalu
use
bootstrap
replic
proport
clinic
characterist
differ
group
patient
compar
use
test
fisher
exact
test
wilcoxon
nonparametr
test
use
compar
age
distribut
length
stay
analys
perform
use
sa
softwar
version
sa
institut
inc
cari
nc
usa
hbov
dna
detect
npa
sampl
symptomat
adult
year
age
symptomat
children
mean
age
month
median
age
month
howev
hbov
detect
frequent
p
asymptomat
control
children
mean
age
month
median
age
month
anoth
viru
detect
hbovposit
npa
symptomat
children
viru
commonli
coisol
hbov
hrsv
follow
infl
uenza
ab
case
hmpv
case
adenoviru
case
parainfl
uenza
viru
case
two
children
infect
virus
addit
hbov
median
age
symptomat
children
hbov
infect
month
signifi
cantli
greater
symptomat
children
without
hbov
infect
month
p
hospit
length
stay
similar
children
posit
hbov
dna
mean
day
median
day
neg
hbov
dna
mean
day
median
day
p
clinic
characterist
hbovposit
children
summar
tabl
signifi
cantli
fewer
bronchiol
episod
children
infect
hbov
children
infect
hrsv
p
none
children
singl
hbov
infect
hbovinfect
children
admit
intens
care
unit
control
group
asymptomat
children
underw
elect
surgeri
ear
nose
throat
surgeri
frequent
perform
children
hbov
infect
children
without
hbov
infect
p
ear
nose
throat
elect
surgeri
consist
mainli
myringotomi
adenoidectomi
tonsillectomi
adult
hbov
infect
man
smoker
came
hospit
copd
exacerb
treat
system
corticosteroid
antimicrobi
drug
microbiolog
agent
bacteria
virus
could
identifi
ed
sputum
npa
hospit
day
sequenc
analysi
hbov
gene
perform
hbovposit
specimen
show
distinct
clade
virus
figur
genotyp
cluster
origin
strain
describ
alland
et
al
genbank
access
genbank
access
tempor
link
clade
equal
distribut
throughout
studi
period
obviou
relationship
found
clade
presenc
absenc
symptom
result
studi
indic
hbov
rare
detect
adult
respiratori
symptom
frequent
detect
symptomat
asymptomat
children
winter
season
hbov
detect
npa
sampl
symptomat
adult
symptomat
children
asymptomat
children
anoth
viru
detect
hbovposit
sampl
symptomat
children
overal
data
support
pathogen
role
hbov
acut
rti
children
full
spectrum
clinic
diseas
associ
hbov
infect
epidemiolog
new
parvoviru
fulli
understood
particularli
true
adult
patient
studi
perform
alland
et
al
found
hbov
dna
cultureneg
npa
sampl
adult
respiratori
symptom
bastien
et
al
report
overal
rate
infect
respiratori
sampl
neg
virus
differ
age
group
maggi
et
al
report
hbovposit
sampl
adult
lymphoma
bronchoalveolar
lavag
bal
investig
also
test
nasal
swab
adult
persist
asthma
symptom
found
sampl
posit
hbov
fri
et
al
identifi
ed
hbov
dna
adult
year
age
hospit
pneumonia
thailand
kupfer
et
al
describ
case
hbov
infect
associ
sever
atyp
pneumonia
patient
nonhodgkin
lymphoma
also
infect
cytomegaloviru
bal
sampl
found
case
hbov
infect
adult
repres
test
popul
hbovposit
adult
show
immunosuppress
treat
corticosteroid
copd
exacerb
overal
result
consist
previous
describ
studi
support
fact
hbov
infect
rare
adult
may
occur
frequent
ill
immunosuppress
studi
report
hbov
dna
children
rti
rate
detect
tend
higher
children
year
age
incid
hbov
infect
also
tend
higher
sampl
lower
respiratori
tract
npa
bal
nasal
swab
percentag
copathogen
hbovposit
children
compar
report
literatur
rate
coinfect
rang
moreov
coinfect
virus
detect
conjunct
hbov
popul
similar
describ
studi
ie
hrsv
infl
uenza
viru
adenoviru
high
frequenc
hbov
detect
asymptomat
children
contrast
result
studi
includ
control
group
asymptomat
children
fri
et
al
detect
hbov
dna
nasal
swab
asymptomat
patient
maggi
et
al
detect
hbov
dna
nasal
swab
asymptomat
children
includ
healthi
infant
mean
age
month
preadolesc
healthi
children
mean
age
year
howev
studi
analyz
nasal
swab
instead
npa
bal
sampl
hbov
detect
may
result
lower
rate
viral
detect
shown
symptomat
person
alland
et
al
detect
hbov
asymptomat
children
median
age
year
rang
month
year
use
nasal
swab
asymptomat
patient
npa
sampl
symptomat
patient
furthermor
control
group
also
older
popul
mean
month
median
month
kesebir
dna
nasal
wash
asymptomat
children
year
age
seen
clinic
compar
variou
sampl
symptomat
children
sent
hospit
clinic
laboratori
none
previou
studi
use
control
group
consist
children
match
age
week
admiss
analyz
type
respiratori
sampl
case
control
posit
result
hbov
confi
rmed
use
set
pcr
primer
target
differ
gene
duplex
pcr
assay
subsequ
test
third
set
primer
sequenc
also
sampl
prepar
pcr
amplifi
cation
perform
separ
laboratori
area
follow
stringent
qualiti
control
program
institut
thu
unlik
posit
result
due
pcr
crosscontamin
method
also
sensit
detect
limit
genom
copi
probabl
enabl
increas
infect
rate
compar
previou
report
exclud
possibl
prior
rti
week
preced
sampl
occur
asymptomat
children
hospit
elect
surgeri
hbov
could
establish
prolong
infect
children
compar
respiratori
virus
howev
higher
detect
rate
control
symptomat
children
make
explan
unlik
quantifi
hbov
dna
load
sampl
studi
could
differ
asymptomat
symptomat
children
nevertheless
detect
hrsv
hmpv
infl
uenza
viru
rna
npa
sampl
asymptomat
children
compar
rate
hbov
dna
least
result
rais
concern
pathogen
role
hbov
children
detect
hbov
genotyp
circul
time
symptomat
asymptomat
children
winter
quebec
result
consist
fi
nding
group
north
america
europ
highlight
fact
hbov
lineag
appear
geograph
cluster
season
hbov
infect
still
matter
debat
seem
involv
primarili
colder
month
year
howev
studi
includ
perform
typic
respiratori
viru
season
may
introduc
bia
addit
studi
need
address
preval
hbov
outsid
respiratori
viru
season
role
nonrespiratori
syndrom
moreov
possibl
viru
might
transmit
isol
respiratori
tract
could
caus
viremia
clinic
syndrom
gastroenter
investig
vicent
et
al
analyz
stool
sampl
children
gastroenter
respiratori
symptom
found
posit
rate
hbov
coinfect
rate
conclus
studi
show
hbov
frequent
detect
symptomat
asymptomat
children
winter
quebec
citi
convers
viru
rare
found
adult
popul
period
studi
need
establish
whether
recent
describ
parvoviru
pathogen
use
wellmatch
control
group
sequenti
sampl
detect
viral
persist
number
along
branch
bootstrap
valu
replic
scale
bar
show
substitut
everi
nucleic
acid
residu
